Huang W F, Lai I C
Institute of Health and Welfare Policy, College of Medicine, National Yang Ming University, Taipei, Taiwan.
Int J Clin Pharmacol Ther. 2006 Jul;44(7):335-42. doi: 10.5414/cpp44335.
This study was based on Taiwan's National Health Insurance (NHI) claim records with the aim of identifying specific types of potentially inappropriate sedative-hypnotic prescribing in elderly outpatients with insomnia. The potentially inappropriate prescribing included duplicate treatment, excessive dosage and duration or treatment and prescribing of hypnotics that are too long-acting.
This cross-sectional study was based on annual outpatient claim data for 2001 released by Taiwan's Bureau of National Health Insurance (BNHI). A subset was created for patients aged 65 years or older and coded as having insomnia. Physician consultation claim data were extracted and merged in 1 claim file consisting of ICD-9-CM codes, patient demographic data, specialty of physicians, medical institution code and pharmaceutical prescription content.
Elderly patients with insomnia constituted 216,994 of the 1,000,193 files surveyed on outpatient claims in 2001. The mean age was 74.33 years and gender distribution was nearly equal. Of the prescribed sleep medications, 41.26% were hypnotic benzodiazepines, 29.36% were hypnotic non-benzodiazepines and 29.38% were sedative-anxiolytics. Approximately 1 in 25 patients (4.12%) of all the patients prescribed hypnotics received duplicate treatment, 1 in 8 an inappropriately (12.27%) high dosage (daily dose > 1.5 DDD, Defined Daily Dose), 1 in 3 (32.25%) more than 28 DDD per prescription and 1 in 6 (17.52%) a drug with an effect which was too prolonged. Physicians tended to consider patient gender but not age when prescribing. Clear trends were found between the specialty of the physician and the type of inappropriate prescribing. The type of medical institution was significantly related only to the excessive quantity of medication prescribed.
Elderly people in Taiwan with insomnia receive potentially inappropriate prescriptions for sleep medications. Similar data could possibly be extracted from similar databases in other countries throughout the world. Some of these potentially inappropriate prescriptions are avoidable in terms of restricting the length of outpatient sedative-hypnotic treatment, introducing hypnotics in small dosage forms and continuously educating clinicians on the safety of geriatric medication.
本研究基于台湾地区国民健康保险(NHI)理赔记录,旨在识别老年失眠门诊患者中潜在不适当的镇静催眠药物处方的特定类型。潜在不适当处方包括重复治疗、剂量和疗程过大或使用长效催眠药物进行治疗和处方。
这项横断面研究基于台湾地区国民健康保险局(BNHI)发布的2001年年度门诊理赔数据。为65岁及以上且编码为患有失眠的患者创建了一个子集。提取医生会诊理赔数据并合并到一个理赔文件中,该文件包括国际疾病分类第九版临床修订本(ICD - 9 - CM)编码、患者人口统计学数据、医生专业、医疗机构编码和药品处方内容。
在2001年调查的1,000,193份门诊理赔文件中,老年失眠患者有216,994例。平均年龄为74.33岁,性别分布几乎相等。在开具的睡眠药物中,41.26%为苯二氮䓬类催眠药,29.36%为非苯二氮䓬类催眠药,29.38%为镇静抗焦虑药。在所有开具催眠药的患者中,约每25名患者中有1名(4.12%)接受了重复治疗,每8名患者中有1名(12.27%)剂量过高(每日剂量>1.5限定日剂量,DDD),每3名患者中有